Objective: The aim of the present study was to evaluate a rat model of placental dysfunction/preeclampsia in pregnancies complicated by maternal diabetes. A second objective was to evaluate the effects of vitamin E treatment in this model.
Methods: Normal and streptozotocin-induced diabetic rats of two different strains (U and H) were given intraperitoneal (IP) injections of the angiogenesis inhibitor Suramin (Sigma Chemical Co, St Louis, MO) or saline in early pregnancy, and fed standard or vitamin E-enriched food. The outcome of pregnancy was evaluated on gestational day 20.
Results: In both rat strains Suramin caused fetal growth retardation, decreased placental blood flow, and increased placental concentration of the isoprostane 8-iso-PGF2α. In the U rats Suramin also caused increased fetal resorption rate, increased maternal blood pressure, decreased renal blood flow, and diminished maternal growth. Diabetes caused severe maternal and fetal growth retardation, increased resorption rate, and increased placental 8-iso-PGF2α, concentration independent of Suramin administration. The maternal and fetal effects of Suramin and diabetes were more pronounced in the U strain than in the H strain. Vitamin E treatment improved the status of Suramin-injected diabetic rats: in U rats the blood pressure increase was normalized; and in both U and H rats the decreased placental blood flow was marginally enhanced, and the increase in placental 8-iso-PGF2α,, was partly normalized by vitamin E.
Conclusion: Suramin injections to pregnant rats cause a state of placental insufficiency, which in U rats resembles human preeclampsia. The induction of this condition is at least partly mediated by oxidative stress, and antagonized by antioxidative treatment. Maternal diabetes involves increased oxidative stress, and causes both maternal and fetal morbidity, which are only marginally affected by additional Suramin treatment.
2. Hubel CA, Roberts JM, Taylor RN, Musci TJ, Rogers GM, McLaughlin MK. Lipid peroxidation in pregnancy: New perspectives on preeclampsia. Am J Obstet Gynecol1989;161:1025-1034.
3.
3. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol1998;179:1359-1375.
4.
4. Hung TH, SkepperJN, Burton GJ. In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol2001;159:1031-1043.
5.
5. Redman CW, Sargent IL. The pathogenesis of pre-eclampsia. Gynecol Obstet Fertil2001;29:518-522.
6.
6. Kauma SW, Wang Y, Walsh SW. Preeclampsia is associated with decreased placental interleukin-6 production. J Soc Gynecol Investig1995;2:614-617.
7.
7. Caniggia I, Winter J, Lye SJ, Post M. Oxygen and placental development dunrng the first trimester: Implications for the pathophysiology of pre-eclampsia. Placenta2000;21(suppl):S25-S30.
8.
8. Amgrimsson R, Bjornsson S, Geirsson RT, Bjornsson H, Walker JJ, Snaedal G. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol1990;97:762-769.
9.
9. Yamada N, Arinami T, Yamakawa-Kobayashi K, et al. The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia. J Hum Genet2000;45:138-141.
10.
10. Treloar SA, Cooper DW, Brennecke SP, Grehan MM, Martin NG. An Australian twin study of the genetic basis of preeclampsia and eclampsia. Am J Obstet Gynecol2001;184:374-381.
11.
11. Wang Y, Walsh S. Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J Soc Gynecol Investig1996;3:179-184.
12.
12. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med1999;222:222-235.
13.
13. Akyol D, Mungan T, Gorkemli H, Nuhoglu G. Maternal levels of vitamin E in normal and preeclamptic pregnancy. Arch Gynecol Obstet2000;263:151-155.
14.
14. Many A, Hubel CA, Fisher SJ, Roberts JM, Zhou Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol2000;156:321-331.
15.
15. Walsh SW, Vaughan JE, Wang Y, Roberts LJ 2nd. Placental isoprostane is significantly increased in preeclampsia. FASEB J2000;14:1289-1296.
16.
16. Staff AC, Ranheim T, Henriksen T, Halvorsen B. 8-Iso-prostaglandin f(2alpha) reduces trophoblast invasion and matrix metalloproteinase activity. Hypertension2000;35:1307-1313.
18. Takacs P, Kauma SW, Sholley MM, Walsh SW, Dinsmoor MJ, Green K. Increased circulating hpid peroxides in severe preeclampsia activate NF-kappaB and upregulate ICAM-1 in vascular endothelial cells. FASEB J2001;15:279-281.
19.
19. Chappell LC, Seed PT, Briley AL, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: A randomized trial. Lancet1999;354:810-816.
20.
20. Chappell LC, Seed PT, Kelly FJ, et al. Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. Am J Obstet Gynecol2002;187:777-784.
21.
21. Combs CA, Rosenn B, Kitzmiller JL, Khoury JC, Wheeler BC, Miodovnik M. Early-pregnancy proteinuria in diabetes related to preeclampsia. Obstet Gynecol1993;82:802-807.
22.
22. Hsu CD, Tan HY, Hong SF, Nickless NA, Copel JA. Strategies for reducing the frequency of preeclampsia in pregnancies with insulin-dependent diabetes mellitus. Am J Perinatol1996;13:265-268.
23.
23. Hanson U, Persson B. Epidemiology of pregnancy-induced hypertension and preeclampsia in type 1 (insulin-dependent) diabetic pregnancies in Sweden. Acta Obstet Gynecol Scand1998;77:620-624.
24.
24. Ros HS, Cnattingius S, Lipworth L. Comparison of risk factors for preeclampsia and gestational hypertension in a populationbased cohort study. Am J Epidemiol1998;147:1062-1070.
25.
25. Hiilesmaa V, Suhonen L, Teramo K. Glycaemic control is associated with pre-eclampsia but not with pregnancy-induced hypertension in women with type I diabetes mellitus. Diabetologia2000;43:1534-1539.
26.
26. West IC. Radicals and oxidative stress in diabetes. Diabet Med2000;17:171-180.
27.
27. Aydin A, Orhan H, Sayal A, Ozata M, Sahin G, Isimer A. Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: Effects of glycemic control. Clin Biochem2001;34:65-70.
28.
28. Sheetz MJ, King GL. Molecular understanding of hyperglycemia's adverse effects for diabetic complications. JAMA2002;288:2579-2588.
29.
29. Ishihara G, Hiramatsu Y, Masuyama H, Kudo T. Streptozotocininduced diabetic pregnant rats exhibit signs and symptoms mimicking preeclampsia. Metabolism2000;49:853-857.
30.
30. Eriksson UJ, Jansson L. Diabetes in pregnancy: decreased placental blood flow and disturbed fetal development in the rat. Pediatr Res1984;18:735-738.
31.
31. Nash P, Wentzel P, Lindeberg S, et al. Placental dysfunction in Suramin-treated rats A new model for pre-eclampsia. Placenta2005 (in press).
32.
32. Eriksson UJ. Importance of genetic predisposition and maternal environment for the occurrence of congenital malformations in offspring of diabetic rats. Teratology1988;37:365-374.
33.
33. Eriksson UJ, Andersson A, Efendic S, Elde R, Hellerström C. Diabetes in pregnancy: effects on the fetal and newborn rat with particular regard to body weight, serum insulin concentration and pancreatic contents of insulin, glucagon and somatostatin. Acta Endocrinol (Copenh)1980;94:354-364.
34.
34. Lowry OH, Rosebrough. NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem1951;193:265-275.
35.
35. Allain CC, Poon LS, Chon CSG, Richmond U, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem1974;20:470-475.
36.
36. Bondar RJL, Mead DC. Evaluation of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides in the hexokinase method for determining glucose in serum. Clin Chem1974;20:586-590.
37.
37. Maas AH. IFCC reference methods and materials for measurement of pH, gases and electrolytes in blood. Scand J Clin Lab Invest1993;214:83-94.
38.
38. Doumas BT. Standards for total serum protein assays-A collaborative study. Clin Chem1975;21:1159-1166.
39.
39. Jacobs NJ, Vandemark PJ. The purification and properties of the alpha-glycerophosphate-oxidizing enzyme of Streptococcus faecalis 1OC1. Arch Biochem Biophys1960;88:250-255.
40.
40. Moshage H, Kok B, Huizenga JR, Jansen PL. Nitrite and nitrate determinations in plasma: A critical evaluation. Clin Chem1995;41:892-896.
41.
41. Pradelles P, Grassi J, MacloufJ. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: An altemative to radioimmunoassay. Anal Chem1985;57:1170-1173.
42.
42. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Med Sci1959;37:911-917.
43.
43. Morrow JD, Harris TM, Roberts LJ 2nd. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: Analytical ramifications for measurement of eicosanoids. Anal Biochem1990;184:1-10.
44.
44. Svensson AM, Bodin B, Andersson A, Jansson L. Pancreatic islet blood flow during pregnancy in the rat: An increased islet mass is associated with decreased islet blood flow. J Endocrinol2004;180:409-415.
45.
45. Gagliardi A, Hadd H, Collins DC. Inhibition of angiogenesis by suramin. Cancer Res1992;52:5073-5075.
46.
46. Bocci G, Danesi R, Benelli U, et al. Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo. Cancer Chemother Pharmacol1999;43:205-212.
47.
47. Zygmunt M, Herr F, Münstedt K, Lang U, Liang OD. Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol2003;110Suppl 1: S10-S18.
48.
48. Bishop ET, Bell GT, Bloor S, Broom IJ, Hendry NF, Wheatley DN. An in vitro model of angiogenesis: Basic features. Angiogenesis1999;3:335-344.
49.
49. Freeman SJ, Lloyd JB. Evidence that suramin and aurothiomalate are teratogenic in rat by disturbing yolk sac-mediated embryonic protein nutrition. Chem Biol Interact1986;58:149-160.
50.
50. Lloyd JB, Beck F. Lysosomes and congenital malformations. Biochem J1969;115:32P-34P.
51.
51. Lee CS, Han JH, Lee SM, et al. Wax moth, Galleria mellonella fat body receptor for high-density lipophorin (HDLp). Arch Insect Biochem Physiol2003;54:14-24.
52.
52. Tannert A, Wustner D, Bechstein J, Muller P, Devaux PF, Herrmann A. Aminophospholipids have no access to the luminal side of the biliary canaliculus: Implications for the specific lipid composition of the bile fluid. J Biol Chem2003;278:40631-40639.
53.
53. Eriksson UJ, Dahlström VE, Lithell HO. Diabetes and pregnancy: Influence of genetic background and maternal diabetic state on the incidence of skeletal malformations in the fetal rat. Acta Endocrinol (Copenh)1986;112Suppl 277:66-73.
54.
54. Eriksson UJ, Styrud J, Eriksson RSM. Diabetes in pregnancy: Genetic and temporal relationships of maldevelopment in the offspring of diabetic rats. In: Sutherland HW, Stowers JM, Pearson DWM, eds. 4th International Colloquium on Carbohydrate Metabolism in Pregnancy and the Newborn. Berlin: SpringerVerlag, 1989:51-63.
55.
55. Styrud J, Thunberg L, Nybacka O, Eriksson UJ. Correlations between matemal metabolism and deranged development in the offspring of normal and diabetic rats. Pediatr Res1995;37:343-353.
56.
56. Wood SM. Assessment of renal functions in hypertensive pregnancies. Clin Obstet Gynaecol1977;4:747-758.
57.
57. Kublickas M, Lunell NO, Nisell H, Westgren M. Matemal renal artery blood flow velocimetry in normal and hypertensive pregnancies. Acta Obstet Gynecol Scand1996;75:715-719.
58.
58. Klein T, Neuhaus K, Reutter F, Nusing RM. Generation of 8-epi-prostaglandin F(2alpha) in isolated rat kidney glomeruli by a radical-independent mechanism. Br J Pharmacol2001;133:643-650.
59.
59. Cederberg J, Basu S, Eriksson UJ. Increased rate of lipid peroxidation and protein carbonylation in experimental diabetic pregnancy. Diabetologia2001;44:766-774.
60.
60. Wentzel P, Welsh N, Eriksson UJ. Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered PGE2 levels in rat embryos exposed to a diabetic environment. Diabetes1999;48:813-820.
61.
61. Eriksson UJ, Borg LAH. Protection by free oxygen radical scavenging enzymes against glucose-induced embryonic malformations in vitro. Diabetologia1991;34:325-331.
62.
62. Simýn CM, Gittenberger-De Groot AC, Wisse B, Eriksson UJ. Malformations in offspring of diabetic rats: Morphometric analysis of neural crest-derived organs and effects of matemal vitamin E treatment. Teratology2000;61:355-367.
63.
63. Sim'an CM, Eriksson UJ. Vitamin E decreases the occurrence of malformations in the offspring of diabetic rats. Diabetes1997;46:1054-1061.
64.
64. Cederberg J, Siman CM, Eriksson UJ. Combined treatment with vitamin E and vitamin C decreases oxidative stress and improves fetal outcome in experimental diabetic pregnancy. Pediatr Res2001;49:755-762.
